Prevalence of hepatitis B in blood donors of the Núcleo de Hemoterapia de Apucarana (Hemepar), state of Paraná, Brazil
Abstract
The prevalence of Hepatitis B was verified in 1,918 blood donors of Apucarana's Haemotherapy Center, state of Paraná, Brazil, from May to December, 1994. Hepatitis B markers (HBsAg, anti-HBc and anti-HBs) were characterized by enzyme immunoassay. The anti-HBs marker was studied in blood donors showing anti-HBc but not HBsAg. The HBsAg prevalence was 0.7% in the general population of blood donors. The prevalence was 1.2% and 0.1% in the first-time donors and non-first-time ones, respectively. The anti-HBc prevalence was 25.5% in the general populations of blood donors, 26,6% in the first-time donors and 23.9% in the others (p=0.09). The anti-HBc/anti-HBs co-positivity was 84.1%. The HBsAg prevalence indicates that this is a low endemicity area. The high prevalence of anti-HBc in negative HBsAg blood donors suggests that this population is under risk of infection.Downloads
Download data is not yet available.
Published
2008-07-17
How to Cite
Colli, L. di, Silveira, T. G. V., & Bertolini, D. A. (2008). Prevalence of hepatitis B in blood donors of the Núcleo de Hemoterapia de Apucarana (Hemepar), state of Paraná, Brazil. Acta Scientiarum. Health Sciences, 21, 363-368. https://doi.org/10.4025/actascihealthsci.v21i0.4458
Issue
Section
Health Sciences
DECLARATION OF ORIGINALITY AND COPYRIGHTS
I Declare that current article is original and has not been submitted for publication, in part or in whole, to any other national or international journal.
The copyrights belong exclusively to the authors. Published content is licensed under Creative Commons Attribution 4.0 (CC BY 4.0) guidelines, which allows sharing (copy and distribution of the material in any medium or format) and adaptation (remix, transform, and build upon the material) for any purpose, even commercially, under the terms of attribution.
Read this link for further information on how to use CC BY 4.0 properly.